Starting a Company Requires Time, Timing, and Temperament

With the explosion of biotechnology and an ever-increasing emphasis on technology transfer from the basic-research laboratory to industry, more and more life scientists are examining the potential economic benefits of their work. Some choose merely to license their patents, but others decide to establish for-profit ventures. Scientists who are also entrepreneurs warn that starting a company is a serious undertaking. It takes a dedicated person with the right temperament who's willing to put in

Written byRobert Finn
| 10 min read

Register for free to listen to this article
Listen with Speechify
0:00
10:00
Share

According to Sandy Weinberg, professor of entrepreneurship at Muhlenberg College, Allentown, Pa., it's critically important for more scientists to enter the business arena. "Right now science decisions are being made by businesspeople, [but] from every social and economic point of view for the [United States], we're much better off if those decisions are not business decisions. The key is to have some science people get a business background and be able to make those decisions themselves."

Experienced scientific entrepreneurs caution that researchers must learn something about business before attempting to start a company. "You need to know the vocabulary of business," advises Weinberg, a biomedical engineer who has founded five companies. "You need to know basic accounting and how to read spreadsheets. You need to understand the concept of marketing. You need to understand the regulatory and legal environment."

Yet gaining this knowledge isn't especially difficult, Weinberg points out. "Scientists ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies